JP2024529918A5 - - Google Patents

Info

Publication number
JP2024529918A5
JP2024529918A5 JP2024503595A JP2024503595A JP2024529918A5 JP 2024529918 A5 JP2024529918 A5 JP 2024529918A5 JP 2024503595 A JP2024503595 A JP 2024503595A JP 2024503595 A JP2024503595 A JP 2024503595A JP 2024529918 A5 JP2024529918 A5 JP 2024529918A5
Authority
JP
Japan
Prior art keywords
antigen
biomarker
item
biomarkers
colorectal cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024503595A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024529918A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/037931 external-priority patent/WO2023004077A2/en
Publication of JP2024529918A publication Critical patent/JP2024529918A/ja
Publication of JP2024529918A5 publication Critical patent/JP2024529918A5/ja
Pending legal-status Critical Current

Links

JP2024503595A 2021-07-21 2022-07-21 結腸直腸がんの検出のための組成物および方法 Pending JP2024529918A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163224378P 2021-07-21 2021-07-21
US63/224,378 2021-07-21
PCT/US2022/037931 WO2023004077A2 (en) 2021-07-21 2022-07-21 Compositions and methods for detection of colorectal cancer

Publications (2)

Publication Number Publication Date
JP2024529918A JP2024529918A (ja) 2024-08-14
JP2024529918A5 true JP2024529918A5 (enExample) 2025-07-30

Family

ID=84978808

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024503595A Pending JP2024529918A (ja) 2021-07-21 2022-07-21 結腸直腸がんの検出のための組成物および方法

Country Status (5)

Country Link
US (1) US20240344139A1 (enExample)
EP (1) EP4373962A4 (enExample)
JP (1) JP2024529918A (enExample)
CA (1) CA3227148A1 (enExample)
WO (1) WO2023004077A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025072135A1 (en) * 2023-09-25 2025-04-03 Mercy Bioanalytics, Inc. Multimodal detection with extracellular vesicles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113748217B (zh) * 2019-03-01 2023-08-25 仁慈生物分析公司 用于靶实体检测的系统、组合物和方法

Similar Documents

Publication Publication Date Title
EP2438197B1 (en) Methods of detecting cancer
JP2022521781A5 (enExample)
US20220162705A1 (en) Method for predicting the response to cancer immunotherapy in cancer patients
JP2023533970A (ja) 肺癌を検出するための組成物及び方法
EP4374173A2 (en) Compositions and methods for cancer detection
US20110217297A1 (en) Methods for classifying and treating breast cancers
JP2023533970A5 (enExample)
Pu et al. Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA
JP2025504786A5 (enExample)
JP2023510911A5 (enExample)
JP2024529386A5 (enExample)
WO2023004083A2 (en) Compositions and methods for detection of bile duct cancer
US20250223649A1 (en) Compositions and methods for detection of lung cancer
WO2023004081A1 (en) Compositions and methods for detection of esophageal cancer
Salem et al. DNA integrity index as a potential molecular biomarker in colorectal cancer
WO2023004082A1 (en) Compositions and methods for detection of prostate cancer
JP2024529918A5 (enExample)
US20240344139A1 (en) Compositions and methods for detection of colorectal cancer
CN110331207A (zh) 肺腺癌生物标志物及相关应用
CN111518914B (zh) 用于检测乳腺癌的miRNA标记物组合、试剂盒和方法
WO2023004080A2 (en) Compositions and methods for detection of pancreatic cancer
Schiemann et al. Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer
Jamaati et al. Three markers in cancerous and healthy cells of patients with non-small-cell lung carcinoma (NSCLC)
CN114672554A (zh) 一种检测肿瘤相关基因谱表达量的方法及其用途
RU2813669C1 (ru) Способ неинвазивной диагностики рака мочевого пузыря на основе выявления опухолевой днк в биологических жидкостях и набор реагентов для его осуществления